Intangible Assets

EH’s brand and trust are limited because the company operates a consumer-facing medical tourism marketplace rather than a regulated healthcare provider, so peer differentiation is easier to replicate than in licensed care networks.

The platform does not appear to own proprietary clinical IP or exclusive medical content that would create durable pricing power versus other cross-border healthcare marketplaces.

Any reputation advantage is fragile because patient choice is highly outcome-sensitive and can shift quickly if peers offer similar hospital access, pricing, or service quality.

Compared with larger travel or healthcare intermediaries, EH’s intangible assets are narrower and less defensible because they depend on service execution rather than exclusive assets or regulated scarcity.

Switching Costs

Patients can switch to another medical tourism platform with low friction because the service is episodic and transaction-based, so retention is weaker than in subscription or workflow software peers.

Hospitals and clinics can multi-home across channels, which limits EH’s ability to lock in supply or raise take rates versus peers.

There is little evidence of embedded clinical workflow integration or long-term contracts that would make EH operationally hard to replace.

Compared with healthcare IT or payment platforms, EH’s switching costs are materially lower because the core service does not sit inside a customer’s daily operating process.

Network Effects

EH may benefit from some two-sided marketplace effects between patients and providers, but the effects are shallow because users can compare options across multiple travel and healthcare sites.

The platform’s network is not clearly self-reinforcing at scale, since a larger provider list does not automatically create exclusive demand or materially higher retention than peers.

Any data advantage from prior bookings is limited because treatment decisions are individualized and not easily converted into a proprietary matching moat.

Compared with dominant marketplaces or payment networks, EH’s network effects are weaker because participation does not appear to be mandatory for either side of the market.

Cost Advantage

EH does not appear to have a structural cost advantage because its service model relies on coordination and marketing rather than proprietary production or distribution economics.

The company’s negative TTM ROIC and ROCE indicate that current economics are not translating into superior unit cost efficiency versus peers.

Asset turnover of 0.22 suggests low asset productivity, which is inconsistent with a durable cost moat relative to more efficient digital intermediaries.

Compared with scaled travel platforms or healthcare distributors, EH lacks evidence of lower structural costs that would support sustained margin outperformance.

Efficient Scale

The medical tourism market is fragmented and contestable, so EH does not appear to operate in a naturally limited niche where one or two players can efficiently dominate.

Because providers and patients can access alternative channels, the company does not seem to benefit from the kind of local or regulatory bottleneck that creates efficient scale.

The business does not show the hallmarks of a protected utility-like position, since competitors can enter with similar digital storefronts and service coordination.

Compared with infrastructure-like healthcare platforms, EH’s scale is not exclusive enough to prevent duplication or materially constrain peer entry.

Overall Score

EH’s moat is weak versus peers because the business appears to rely on a replicable marketplace model with low switching costs, limited network depth, and no clear cost or scale barrier that would sustain pricing power over 5–10 years.